FDA NDC Directory · JSON-LD · Markdown

Posaconazole

NDC 63323-685 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerFresensius Kabi USA, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA209983
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsPOSACONAZOLE (18 mg/mL)
Marketing started20231226
Package count1

External sources

Source: openFDA. Public-domain (CC0).